Related Experiment Video
Updated: Oct 2, 2025
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting
Nan Li1,2,3, Kai Yu4, Zhong Lin5
1Reproductive Medicine Center, Liuzhou Maternity and Child Health Care Hospital, Liuzhou 545001, China.
Background:
Nearly half of patients with prostate cancer will develop metastasis. Immunotherapy is currently a promising strategy for treating metastatic prostate cancer. This study aimed to construct an immune subtyping system and provide a more comprehensive understanding of tumor microenvironment.
Methods:
Data were downloaded from TCGA database and cBioPortal database. Consensus clustering was used to identify immune subtypes. Immune features were scored by ESTIMATE and CIBERSORT. Efficacy of different subtypes in immunotherapy was predicted by TIDE tool. Immune landscape was delineated through "monocle." Coexpressed gene modules were identified by weighted correlation network analysis. Univariate Cox regression analysis and LASSO analysis were applied to construct a prognostic model.
Results:
Four immune subtypes (IS1 to IS4) were identified. Prognosis, mutation patterns, expression of immune genes, immune biomarkers, immunohistochemical biomarkers, and prediction efficacy of immunotherapy were significantly different among four immune subtypes. Five coexpressed gene modules were identified and an 11-gene prognostic model was constructed based on the modules.
Conclusions:
The study developed a novel immune subtyping system and an 11-gene prognostic model of prostate cancer, which could guide personalized treatment and immunotherapy for patients with prostate cancer.
